Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, 48688-48689 [2024-12538]
Download as PDF
<![CDATA[
48688
Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Notices
Background
On April 19, 2024, by the Coalition
for Fair Trade in Ceramic Tile 4 filed
petitions with the Commission and
Commerce, alleging that an industry in
the United States is materially injured
or threatened with material injury by
reason of subsidized imports of ceramic
tile from India and LTFV imports of
ceramic tile from India. Accordingly,
effective April 19, 2024, the
Commission instituted countervailing
duty investigation No. 701–TA–720 and
antidumping duty investigation No.
731–TA–1688 (Preliminary).
Notice of the institution of the
Commission’s investigations and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of April 25, 2024 (89
FR 31770). The Commission conducted
its conference on May 10, 2024. All
persons who requested the opportunity
were permitted to participate.
The Commission made these
determinations pursuant to §§ 703(a)
and 733(a) of the Act (19 U.S.C.
1671b(a) and 1673b(a)). It completed
and filed its determinations in these
investigations on May 31, 2024. The
views of the Commission are contained
in USITC Publication 5515 (June 2024),
entitled Ceramic Tile from India:
Investigation Nos. 701–TA–720 and
731–TA–1688 (Preliminary).
By order of the Commission.
Issued: June 3, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–12476 Filed 6–6–24; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
Notice of Receipt of Complaint;
Solicitation of Comments Relating to
the Public Interest
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
4 The Coalition for Fair Trade in Ceramic Tile is
comprised of Crossville, Inc., Crossville, TN; DalTile Corporation, Dallas, TX; Del Conca USA, Inc.,
Loudon, TN; Wonder Porcelain, Lebanon, TN;
Landmark Ceramics—UST, Inc., Mount Pleasant,
TN; Florim USA, Clarksville, TN; Florida Tile,
Lexington, KY; Portobello America Manufacturing
LLC, Pompano Beach, FL; and StonePeak Ceramics
Inc., Chicago, IL.
VerDate Sep<11>2014
17:23 Jun 06, 2024
Jkt 262001
Commission has received a complaint
Certain Memory Devices and Electronic
Devices Containing the Same, DN 3751;
the Commission is soliciting comments
on any public interest issues raised by
the complaint or complainant’s filing
pursuant to the Commission’s Rules of
Practice and Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa
R. Barton, Secretary to the Commission,
U.S. International Trade Commission,
500 E Street SW, Washington, DC
20436, telephone (202) 205–2000. The
public version of the complaint can be
accessed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
For help accessing EDIS, please email
EDIS3Help@usitc.gov.
General information concerning the
Commission may also be obtained by
accessing its internet server at United
States International Trade Commission
(USITC) at https://www.usitc.gov. The
public record for this investigation may
be viewed on the Commission’s
Electronic Document Information
System (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised
that information on this matter can be
obtained by contacting the
Commission’s TDD terminal on (202)
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission has received a complaint
and a submission pursuant to § 210.8(b)
of the Commission’s Rules of Practice
and Procedure filed on behalf of
MimirIP LLC on June 3, 2024. The
complaint alleges violations of section
337 of the Tariff Act of 1930 (19 U.S.C.
1337) in the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain memory devices
and electronic devices containing the
same. The complaint names as a
respondent: Micron Technology Inc. of
Boise, ID; Dell, Inc. of Round Rock, TX;
Hewlett Packard Enterprise Co. of
Spring, TX; HP, Inc. of Palo Alto, CA;
Kingston Technology Company, Inc. of
Fountain Valley, CA; Lenovo Group
Limited of China; Lenovo (United
States) Inc. of Morrisville, NC; and Tesla
Inc. of Austin, TX. The complainant
requests that the Commission issue a
limited exclusion order, cease and
desist orders, and impose a bond upon
respondent alleged infringing articles
during the 60-day Presidential review
period pursuant to 19 U.S.C. 1337(j).
Proposed respondents, other
interested parties, and members of the
public are invited to file comments on
any public interest issues raised by the
complaint or § 210.8(b) filing.
Comments should address whether
PO 00000
Frm 00139
Fmt 4703
Sfmt 4703
issuance of the relief specifically
requested by the complainant in this
investigation would affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) explain how the articles potentially
subject to the requested remedial orders
are used in the United States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the requested remedial
orders;
(iii) identify like or directly
competitive articles that complainant,
its licensees, or third parties make in the
United States which could replace the
subject articles if they were to be
excluded;
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due, notwithstanding § 201.14(a)
of the Commission’s Rules of Practice
and Procedure. No other submissions
will be accepted, unless requested by
the Commission. Any submissions and
replies filed in response to this Notice
are limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. Submissions should refer
to the docket number (‘‘Docket No.
3751’’) in a prominent place on the
cover page and/or the first page. (See
Handbook for Electronic Filing
E:\FR\FM\07JNN1.SGM
07JNN1
48689
Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Notices
Procedures, Electronic Filing
Procedures 1).
Please note the Secretary’s Office will
accept only electronic filings during this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at EDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. appendix 3; or (ii) by U.S.
Government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 4, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–12538 Filed 6–6–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1382]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 6, 2024. Such
persons may also file a written request
for a hearing on the application on or
before August 6, 2024.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 8, 2024, American
Radiolabeled Chem, 101 Arc Drive,
Saint Louis, Missouri 63146–3502,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
American Radiolabeled Chem
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...............................................................................................................................................
Ibogaine ...............................................................................................................................................................................
Lysergic acid diethylamide ..................................................................................................................................................
Tetrahydrocannabinols ........................................................................................................................................................
Dimethyltryptamine ..............................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Heroin ..................................................................................................................................................................................
Normorphine ........................................................................................................................................................................
Amphetamine .......................................................................................................................................................................
Methamphetamine ...............................................................................................................................................................
Amobarbital ..........................................................................................................................................................................
Phencyclidine .......................................................................................................................................................................
Phenylacetone .....................................................................................................................................................................
Cocaine ................................................................................................................................................................................
Codeine ...............................................................................................................................................................................
Dihydrocodeine ....................................................................................................................................................................
Oxycodone ...........................................................................................................................................................................
Hydromorphone ...................................................................................................................................................................
Ecgonine ..............................................................................................................................................................................
Hydrocodone .......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Metazocine ..........................................................................................................................................................................
Methadone ...........................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
VerDate Sep<11>2014
17:23 Jun 06, 2024
Jkt 262001
2 All contract personnel will sign appropriate
nondisclosure agreements.
PO 00000
Frm 00140
Fmt 4703
Sfmt 4703
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 89, Number 111 (Friday, June 7, 2024)]
[Notices]
[Pages 48688-48689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12538]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
Notice of Receipt of Complaint; Solicitation of Comments Relating
to the Public Interest
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has received a complaint Certain Memory Devices and
Electronic Devices Containing the Same, DN 3751; the Commission is
soliciting comments on any public interest issues raised by the
complaint or complainant's filing pursuant to the Commission's Rules of
Practice and Procedure.
FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the
Commission, U.S. International Trade Commission, 500 E Street SW,
Washington, DC 20436, telephone (202) 205-2000. The public version of
the complaint can be accessed on the Commission's Electronic Document
Information System (EDIS) at https://edis.usitc.gov. For help accessing
EDIS, please email [email protected].
General information concerning the Commission may also be obtained
by accessing its internet server at United States International Trade
Commission (USITC) at https://www.usitc.gov. The public record for this
investigation may be viewed on the Commission's Electronic Document
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired
persons are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on (202) 205-1810.
SUPPLEMENTARY INFORMATION: The Commission has received a complaint and
a submission pursuant to Sec. 210.8(b) of the Commission's Rules of
Practice and Procedure filed on behalf of MimirIP LLC on June 3, 2024.
The complaint alleges violations of section 337 of the Tariff Act of
1930 (19 U.S.C. 1337) in the importation into the United States, the
sale for importation, and the sale within the United States after
importation of certain memory devices and electronic devices containing
the same. The complaint names as a respondent: Micron Technology Inc.
of Boise, ID; Dell, Inc. of Round Rock, TX; Hewlett Packard Enterprise
Co. of Spring, TX; HP, Inc. of Palo Alto, CA; Kingston Technology
Company, Inc. of Fountain Valley, CA; Lenovo Group Limited of China;
Lenovo (United States) Inc. of Morrisville, NC; and Tesla Inc. of
Austin, TX. The complainant requests that the Commission issue a
limited exclusion order, cease and desist orders, and impose a bond
upon respondent alleged infringing articles during the 60-day
Presidential review period pursuant to 19 U.S.C. 1337(j).
Proposed respondents, other interested parties, and members of the
public are invited to file comments on any public interest issues
raised by the complaint or Sec. 210.8(b) filing. Comments should
address whether issuance of the relief specifically requested by the
complainant in this investigation would affect the public health and
welfare in the United States, competitive conditions in the United
States economy, the production of like or directly competitive articles
in the United States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) explain how the articles potentially subject to the requested
remedial orders are used in the United States;
(ii) identify any public health, safety, or welfare concerns in the
United States relating to the requested remedial orders;
(iii) identify like or directly competitive articles that
complainant, its licensees, or third parties make in the United States
which could replace the subject articles if they were to be excluded;
(iv) indicate whether complainant, complainant's licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to the requested exclusion order and/or a
cease and desist order within a commercially reasonable time; and
(v) explain how the requested remedial orders would impact United
States consumers.
Written submissions on the public interest must be filed no later
than by close of business, eight calendar days after the date of
publication of this notice in the Federal Register. There will be
further opportunities for comment on the public interest after the
issuance of any final initial determination in this investigation. Any
written submissions on other issues must also be filed by no later than
the close of business, eight calendar days after publication of this
notice in the Federal Register. Complainant may file replies to any
written submissions no later than three calendar days after the date on
which any initial submissions were due, notwithstanding Sec. 201.14(a)
of the Commission's Rules of Practice and Procedure. No other
submissions will be accepted, unless requested by the Commission. Any
submissions and replies filed in response to this Notice are limited to
five (5) pages in length, inclusive of attachments.
Persons filing written submissions must file the original document
electronically on or before the deadlines stated above. Submissions
should refer to the docket number (``Docket No. 3751'') in a prominent
place on the cover page and/or the first page. (See Handbook for
Electronic Filing
[[Page 48689]]
Procedures, Electronic Filing Procedures \1\).
---------------------------------------------------------------------------
\1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------
Please note the Secretary's Office will accept only electronic
filings during this time. Filings must be made through the Commission's
Electronic Document Information System (EDIS, https://edis.usitc.gov.)
No in-person paper-based filings or paper copies of any electronic
filings will be accepted until further notice. Persons with questions
regarding filing should contact the Secretary at [email protected].
Any person desiring to submit a document to the Commission in
confidence must request confidential treatment. All such requests
should be directed to the Secretary to the Commission and must include
a full statement of the reasons why the Commission should grant such
treatment. See 19 CFR 201.6. Documents for which confidential treatment
by the Commission is properly sought will be treated accordingly. All
information, including confidential business information and documents
for which confidential treatment is properly sought, submitted to the
Commission for purposes of this Investigation may be disclosed to and
used: (i) by the Commission, its employees and Offices, and contract
personnel (a) for developing or maintaining the records of this or a
related proceeding, or (b) in internal investigations, audits, reviews,
and evaluations relating to the programs, personnel, and operations of
the Commission including under 5 U.S.C. appendix 3; or (ii) by U.S.
Government employees and contract personnel,\2\ solely for
cybersecurity purposes. All nonconfidential written submissions will be
available for public inspection at the Office of the Secretary and on
EDIS.\3\
---------------------------------------------------------------------------
\2\ All contract personnel will sign appropriate nondisclosure
agreements.
\3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.
---------------------------------------------------------------------------
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure
(19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 4, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-12538 Filed 6-6-24; 8:45 am]
BILLING CODE 7020-02-P
